John Kirby

Chief Financial Officer

John is Aceragen’s Chief Financial Officer, having held the same role at Idera Pharmaceuticals since 2019 and transitioning to the Aceragen team as part of the 2022 merger between the two companies. He has gained more than 25 years of public-company finance and business experience from his roles in public accounting and with small to mid-sized public pharma companies. He also currently serves on the board of trustees of the Delaware Museum of Nature and Science.

Before joining Idera in 2015, John served as Assistant Controller at Endo Pharmaceuticals and, prior to that, as Vice President, Chief Accounting Officer and Corporate Controller at ViroPharma Incorporated. John began his career at KPMG, LLP and served as a Regional Audit Director at AstraZeneca Pharmaceuticals prior to joining ViroPharma. John received his Bachelor of Science from Villanova University and is a licensed certified public accountant.